Precision Medicine and Targeted Therapies in Oncology: Advancements in Drug Discovery and Clinical Applications

Clicks: 2
ID: 311280
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #26 of 34 articles by views in Journal of Clinical Advances and Research Reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Aim: Evaluation of the frequency of different cancer kinds, evaluation of patient responses to targeted treatments, analysis of treatment-related side events, and investigation of the influence of insurance coverage on access to these medicines are the objectives of this research. Purpose: The goal is to comprehend patient side effects, the efficacy of targeted medicines, and the function of insurance in facilitating treatment access. The purpose of this study is to provide insights that help improve patient outcomes and therapy for cancer. Method: A descriptive cross-sectional technique was used to assess 200 cancer patients who were undergoing targeted treatment. Standardized questionnaires were used to gather information on the different types of cancer, treatment outcomes, side effects, insurance coverage status, and demographics. Result: Key data showed that the most common cancer was lung cancer (20%), which was followed by colorectal cancer (15%) and breast cancer (17.5%). In response to treatment, 15% had a full response, 30% had a partial response, 35% stayed stable, and 20% saw their condition advance. Fever (20%), nausea (25%), and hair loss (15%) were among the adverse effects. In terms of insurance, 10% were uninsured, 40% had limited coverage, and 50% had complete coverage. Conclusion: The research emphasizes the significance of insurance coverage, the variety of therapy responses, and the intricacies of cancer treatment in precision medicine. To enhance therapeutic approaches and provide better access to vital therapies, which will ultimately improve patient care overall, more research is required.
Reference Key
imported_1770374358_6985c4d6dc1a7 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Namrata Bhutani, Bhavit Bansal, Soumik Chatterjee, Evana Raj, Asutosh Pradhan
Journal Journal of Clinical Advances and Research Reviews
Year 2024
DOI
10.62896/jcarr.v1.i2.04
URL
https://jcarr.in/index.php/files/article/view/111
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.